171 related articles for article (PubMed ID: 12840208)
1. Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase.
Wang S; DeGroff VL; Clinton SK
J Nutr; 2003 Jul; 133(7):2367-76. PubMed ID: 12840208
[TBL] [Abstract][Full Text] [Related]
2. Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells.
Klein RD; Fischer SM
Carcinogenesis; 2002 Jan; 23(1):217-21. PubMed ID: 11756245
[TBL] [Abstract][Full Text] [Related]
3. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
Kim EJ; Shin HK; Park JH
J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
Kawase T; Orikasa M; Ogata S; Burns DM
Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
[TBL] [Abstract][Full Text] [Related]
5. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
Annerén C; Welsh M
Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
[TBL] [Abstract][Full Text] [Related]
6. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
Yau L; Lukes H; McDiarmid H; Werner J; Zahradka P
Eur J Biochem; 1999 Dec; 266(3):1147-57. PubMed ID: 10583412
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
Kurihara S; Hakuno F; Takahashi S
Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I-induced DNA synthesis in insulin-secreting cell line RINm5F is associated with phosphorylation of the insulin-like growth factor-I receptor and the insulin receptor substrate-2.
Zhang Q; Berggren PO; Hansson A; Tally M
J Endocrinol; 1998 Mar; 156(3):573-81. PubMed ID: 9582514
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
Lee J; Ju J; Park S; Hong SJ; Yoon S
Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
[TBL] [Abstract][Full Text] [Related]
11. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
12. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
Hermanto U; Zong CS; Li W; Wang LH
Mol Cell Biol; 2002 Apr; 22(7):2345-65. PubMed ID: 11884618
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
14. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
[TBL] [Abstract][Full Text] [Related]
15. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study.
Shukla S; Gupta S
Mol Carcinog; 2009 Mar; 48(3):243-252. PubMed ID: 18726972
[TBL] [Abstract][Full Text] [Related]
16. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
[TBL] [Abstract][Full Text] [Related]
17. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
19. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
Jackson JG; White MF; Yee D
J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
